{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:03:54Z","timestamp":1790615034185,"version":"4.1.0"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cellsig.2020.109639","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T20:39:16Z","timestamp":1587415156000},"page":"109639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["STAT signaling in polycystic kidney disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Sebastian","family":"Strubl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison K.","family":"Spindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max C.","family":"Liebau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9423-5561","authenticated-orcid":false,"given":"Thomas","family":"Weimbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2020.109639_bb0005","doi-asserted-by":"crossref","DOI":"10.5414\/CN109927Letter","article-title":"Doubts about the efficacy of tolvaptan for polycystic kidney disease","author":"Anderson","year":"2020","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0394632015623794","article-title":"Analysis of changes in expression of IL-4\/IL-13\/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma","volume":"29","author":"Antczak","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","article-title":"STAT3 in cancer: a double edged sword","volume":"98","author":"Avalle","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.cellsig.2020.109639_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01982","article-title":"Suppressor of cytokine signaling-1\/STAT1 regulates renal inflammation in mesangial proliferative glomerulonephritis models","volume":"9","author":"Bai","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0025","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2353\/ajpath.2008.080125","article-title":"Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease","volume":"173","author":"Banales","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40265-014-0212-x","article-title":"Teriflunomide and its mechanism of action in multiple sclerosis","volume":"74","author":"Bar-Or","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.cellsig.2020.109639_bb0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.06.006","article-title":"Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?","volume":"191","author":"Beebe","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cellsig.2020.109639_bb0040","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.171.8.3919","article-title":"Specific inhibition of Stat5a\/b promotes apoptosis of IL-2-responsive primary and tumor-derived lymphoid cells","volume":"171","author":"Behbod","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1523-1755.2001.00768.x","article-title":"Angiogenesis in autosomal-dominant polycystic kidney disease","volume":"60","author":"Bello-Reuss","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cellsig.2020.109639_bb0055","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1074\/jbc.M109.017756","article-title":"Polycystin-1 C-terminal cleavage is modulated by polycystin-2 expression","volume":"284","author":"Bertuccio","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0060","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0092-8674(02)00716-X","article-title":"PKD1 induces p21waf1 and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2","volume":"109","author":"Bhunia","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0065","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1681\/ASN.2015091014","article-title":"Stat3 controls tubulointerstitial communication during CKD","volume":"27","author":"Bienaim\u00e9","year":"2016","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb0070","doi-asserted-by":"crossref","first-page":"F1689","DOI":"10.1152\/ajprenal.90333.2008","article-title":"JAK2\/Y343\/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cells","volume":"295","author":"Breggia","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0080","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2018050518","article-title":"Mcp1 promotes macrophage-dependent cyst expansion in autosomal dominant polycystic kidney disease","volume":"29","author":"Cassini","year":"2018","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12860-015-0059-3","article-title":"Regulation of the microtubular cytoskeleton by Polycystin-1 favors focal adhesions turnover to modulate cell adhesion and migration","volume":"16","author":"Castelli","year":"2015","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.kint.2016.01.026","article-title":"Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease","volume":"90","author":"Cebotaru","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0095","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI21753","article-title":"Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus","volume":"114","author":"Chauvet","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109639_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/ijms17040565","article-title":"The role of galectin-3 in the kidneys","volume":"17","author":"Chen","year":"2016","journal-title":"IJMS"},{"key":"10.1016\/j.cellsig.2020.109639_bb0105","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.2013010076","article-title":"Survivin mediates renal proximal tubule recovery from AKI","volume":"24","author":"Chen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2174\/18715206113139990115","article-title":"Molecular evidence of cryptotanshinone for treatment and prevention of human cancer","volume":"13","author":"Chen","year":"2013","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0115","doi-asserted-by":"crossref","first-page":"50023","DOI":"10.18632\/oncotarget.18483","article-title":"Cryptotanshinone inhibits proliferation yet induces apoptosis by suppressing STAT3 signals in renal cell carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2020.109639_bb0120","article-title":"JAK-STAT6 pathway inhibitors block eotaxin-3 secretion by epithelial cells and fibroblasts from esophageal eosinophilia patients: promising agents to improve inflammation and prevent fibrosis in EoE","volume":"11","author":"Cheng","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellsig.2020.109639_bb0125","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1073\/pnas.0903487106","article-title":"Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes","volume":"106","author":"Cheon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/jir.2010.0100","article-title":"The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins","volume":"31","author":"Cheon","year":"2011","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1165\/rcmb.2008-0163OC","article-title":"A Novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice","volume":"41","author":"Chiba","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2353\/ajpath.2006.060245","article-title":"Galectin-3 associates with the primary cilium and modulates cyst growth in congenital polycystic kidney disease","volume":"169","author":"Chiu","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2020.109639_bb0150","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0155","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1128\/MCB.00851-09","article-title":"Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1","volume":"30","author":"Creamer","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0160","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1038\/sj.onc.1210222","article-title":"Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer","volume":"26","author":"Cui","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109639_bb0165","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1128\/MCB.24.18.8037-8047.2004","article-title":"Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation","volume":"24","author":"Cui","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0170","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/ml500165r","article-title":"Nanomolar-potency small molecule inhibitor of STAT5 protein","volume":"5","author":"Cumaraswamy","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cellsig.2020.109639_bb0175","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00018-016-2394-8","article-title":"Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2\/STAT3 signaling axis","volume":"74","author":"Dalagiorgou","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2020.109639_bb0180","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/0961203306075383","article-title":"Activation of the STAT1 signalling pathway in lupus nephritis in MRL\/lpr mice","volume":"16","author":"Dong","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.cellsig.2020.109639_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41581-019-0143-6","article-title":"Structure and function of polycystins: insights into polycystic kidney disease","volume":"15","author":"Douguet","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2018.05.207","article-title":"S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL\/lpr mice","volume":"503","author":"Du","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2020.109639_bb0195","doi-asserted-by":"crossref","first-page":"4609502","DOI":"10.1155\/2017\/4609502","article-title":"Endothelial STAT3 modulates protective mechanisms in a mouse ischemia-reperfusion model of acute kidney injury","volume":"2017","author":"Dube","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0205","doi-asserted-by":"crossref","first-page":"C522","DOI":"10.1152\/ajpcell.00163.2010","article-title":"c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation","volume":"301","author":"Elliott","year":"2011","journal-title":"Am. J. Phys. Cell Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41598-017-00920-3","article-title":"Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b","volume":"7","author":"Elumalai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2020.109639_bb0215","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7326\/0003-4819-159-6-201309170-00004","article-title":"Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease","volume":"159","author":"Erickson","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98214","article-title":"Kr\u00fcppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation","volume":"3","author":"Estrada","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.cellsig.2020.109639_bb0225","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.str.2011.06.011","article-title":"Structural basis of substrate methylation and inhibition of SMYD2","volume":"19","author":"Ferguson","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.cellsig.2020.109639_bb0230","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/jdv.14342","article-title":"STAT4 expression and activation is increased during mitosis in vitro and in vivo in skin- and mucosa-derived cell types: implications in neoplastic and inflammatory skin diseases","volume":"31","author":"Ferreli","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0235","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3","volume":"181","author":"Fielding","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0240","doi-asserted-by":"crossref","first-page":"F210","DOI":"10.1152\/ajprenal.00389.2017","article-title":"Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade","volume":"314","author":"Fitzgibbon","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/cei.12285","article-title":"Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study: Expression of IL-19 and IL-24 in IBD patients","volume":"177","author":"Fonseca-Camarillo","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0250","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.kint.2016.10.039","article-title":"STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease","volume":"91","author":"Fragiadaki","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/hep.24765","article-title":"Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer","volume":"55","author":"Friedbichler","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cellsig.2020.109639_bb0260","first-page":"43","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"ANM"},{"key":"10.1016\/j.cellsig.2020.109639_bb0265","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0270","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.39473","article-title":"VX-509 (Decernotinib), an oral selective JAK-3 inhibitor, in combination with methotrexate in patients with rheumatoid arthritis","volume":"68","author":"Genovese","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.cellsig.2020.109639_bb0275","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/S0140-6736(18)31116-4","article-title":"Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial","volume":"391","author":"Genovese","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2020.109639_bb0280","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1074\/jbc.M109.060301","article-title":"Cell-cell contact formation governs Ca 2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-\u03b2-Catenin Interaction","volume":"285","author":"Graziani","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0285","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1096-6374(00)80004-0","article-title":"Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors","volume":"10","author":"Groner","year":"2000","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0290","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thoraxjnl-2014-206719","article-title":"Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies","volume":"70","author":"Hanania","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.cellsig.2020.109639_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2013.03.014","article-title":"STAT signaling in mammary gland differentiation, cell survival and tumorigenesis","volume":"382","author":"Haricharan","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0300","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S2352-3026(17)30088-1","article-title":"Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study","volume":"4","author":"Harrison","year":"2017","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0305","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2353\/ajpath.2008.070726","article-title":"Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis","volume":"172","author":"Henderson","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0310","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.trecan.2017.10.004","article-title":"Targeting oncogenic transcription factors: therapeutic implications of endogenous STAT inhibitors","volume":"3","author":"Heppler","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.cellsig.2020.109639_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellsig.2020.109639_bb0320","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00020.2007","article-title":"Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells","volume":"293","author":"Huang","year":"2007","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0325","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jcb.25058","article-title":"Cinnamaldehyde and nitric oxide attenuate advanced glycation end products-induced the JAK\/STAT signaling in human renal tubular cells","volume":"116","author":"Huang","year":"2015","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0330","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1681\/ASN.2014060612","article-title":"GM-CSF promotes macrophage alternative activation after renal ischemia\/reperfusion injury","volume":"26","author":"Huen","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","article-title":"Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis","volume":"176","author":"Humphreys","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0340","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)81277-5","article-title":"STATs: signal transducers and activators of transcription","volume":"84","author":"Ihle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0345","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1172\/JCI0215518","article-title":"Evidence that fibroblasts derive from epithelium during tissue fibrosis","volume":"110","author":"Iwano","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109639_bb0350","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/sj.onc.1202238","article-title":"Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK)","volume":"17","author":"Jain","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109639_bb0355","doi-asserted-by":"crossref","first-page":"F479","DOI":"10.1152\/ajprenal.00329.2017","article-title":"Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway","volume":"315","author":"Jing","year":"2018","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0360","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb0365","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","article-title":"IL-13 activates a mechanism of tissue fibrosis that is completely TGF-\u03b2 independent","volume":"173","author":"Kaviratne","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0370","doi-asserted-by":"crossref","first-page":"22484","DOI":"10.1074\/jbc.274.32.22484","article-title":"Differential effects of prolactin and src\/abl kinases on the nuclear translocation of STAT5B and STAT5A","volume":"274","author":"Kazansky","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0375","doi-asserted-by":"crossref","first-page":"F277","DOI":"10.1152\/ajprenal.00004.2018","article-title":"STAT1 regulates macrophage number and phenotype and prevents renal fibrosis after ischemia-reperfusion injury","volume":"316","author":"Kemmner","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0380","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.kint.2018.06.025","article-title":"CD8+ T cells modulate autosomal dominant polycystic kidney disease progression","volume":"94","author":"Kleczko","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0385","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/nar\/gkn166","article-title":"The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation","volume":"36","author":"Kleinschmidt","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0390","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1074\/jbc.RA117.000567","article-title":"Small molecule targeting of the STAT5\/6 Src homology 2 (SH2) domains to inhibit allergic airway disease","volume":"293","author":"Knight","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0395","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.coph.2012.06.008","article-title":"Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease","volume":"12","author":"Kontzias","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1681\/ASN.2019020113","article-title":"Periostin promotes cell proliferation and macrophage polarization to drive repair after AKI","volume":"31","author":"Kormann","year":"2020","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb0405","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/art.24567","article-title":"The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo","volume":"60","author":"Kremer","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellsig.2020.109639_bb0410","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.2013050528","article-title":"Toll-like receptor 4-induced IL-22 accelerates kidney regeneration","volume":"25","author":"Kulkarni","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0415","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1440-1797.2007.00881.x","article-title":"Signal transducer and activator of transcription 3 involvement in the development of renal interstitial fibrosis after unilateral ureteral obstruction","volume":"12","author":"Kuratsune","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.cellsig.2020.109639_bb0420","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1038\/s41598-018-21873-1","article-title":"G\u03b1i-mediated TRPC4 activation by polycystin-1 contributes to endothelial function via STAT1 activation","volume":"8","author":"Kwak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2020.109639_bb0425","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/MCB.16.1.369","article-title":"Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor","volume":"16","author":"Leaman","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0430","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1074-7613(02)00336-9","article-title":"STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation","volume":"17","author":"Lee","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2020.109639_bb0440","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0445","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/bbrc.1999.0780","article-title":"Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain","volume":"259","author":"Li","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2020.109639_bb0450","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.kint.2017.04.021","article-title":"The IL-4 receptor \u03b1 has a critical role in bone marrow-derived fibroblast activation and renal fibrosis","volume":"92","author":"Liang","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0455","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.22756","article-title":"Evolution of the JAK-STAT pathway","volume":"2","author":"Liongue","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.cellsig.2020.109639_bb0460","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2369-13-109","article-title":"Increasing extracellular matrix collagen level and MMP activity induces cyst development in polycystic kidney disease","volume":"13","author":"Liu","year":"2012","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0465","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.devcel.2005.12.005","article-title":"Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease","volume":"10","author":"Low","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166272","article-title":"Galectin-3 blockade reduces renal fibrosis in two normotensive experimental models of renal damage","volume":"11","author":"Martinez-Martinez","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2020.109639_bb0475","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1046\/j.1523-1755.2003.00874.x","article-title":"Activation of the ERK pathway precedes tubular proliferation in the obstructed rat kidney","volume":"63","author":"Masaki","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0480","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.4049\/jimmunol.0902960","article-title":"Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function","volume":"184","author":"Melillo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0485","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0092-8674(00)81288-X","article-title":"Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway","volume":"84","author":"Meraz","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0490","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00467-013-2548-y","article-title":"Polycystin-1 cleavage and the regulation of transcriptional pathways","volume":"29","author":"Merrick","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0495","series-title":"Ruxolitinib","author":"Mesa","year":"2012"},{"key":"10.1016\/j.cellsig.2020.109639_bb0500","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10799893.2017.1365902","article-title":"High glucose induces HGF-independent activation of Met receptor in human renal tubular epithelium","volume":"37","author":"Mesarosova","year":"2017","journal-title":"J. Recept. Signal. Transduct."},{"key":"10.1016\/j.cellsig.2020.109639_bb0505","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1073\/pnas.022628499","article-title":"Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1)","volume":"99","author":"Metcalf","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0510","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","article-title":"Therapeutic modulators of STAT signalling for human diseases","volume":"12","author":"Miklossy","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2020.109639_bb0515","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellsig.2020.109639_bb0520","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/ckj\/sfy103","article-title":"Management of autosomal-dominant polycystic kidney disease-state-of-the-art","volume":"11","author":"M\u00fcller","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cellsig.2020.109639_bb0525","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1164\/rccm.200410-1420OC","article-title":"Niflumic acid suppresses interleukin-13\u2013induced asthma phenotypes","volume":"173","author":"Nakano","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0530","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1073\/pnas.1714102115","article-title":"IRF9 and unphosphorylated STAT2 cooperate with NF-\u03baB to drive IL6 expression","volume":"115","author":"Nan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0535","series-title":"Gene Activation by the Cytokine-Driven Transcription Factor STAT1","author":"Nast","year":"2019"},{"key":"10.1016\/j.cellsig.2020.109639_bb0540","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1681\/ASN.2007070744","article-title":"IL-6\/IL-6R axis plays a critical role in acute kidney injury","volume":"19","author":"Nechemia-Arbely","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0545","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4049\/jimmunol.172.1.464","article-title":"Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer","volume":"172","author":"Nefedova","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0550","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Nelson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cellsig.2020.109639_bb0560","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2013.03.051","article-title":"Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids","volume":"132","author":"Noonan","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005734","article-title":"The inflammatory transcription factors NF\u03baB, STAT1 and STAT3 drive age-associated transcriptional changes in the human kidney","volume":"11","author":"O\u2019Brown","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.cellsig.2020.109639_bb0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejphar.2008.06.035","article-title":"YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models","volume":"590","author":"Ohga","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0575","doi-asserted-by":"crossref","first-page":"17209","DOI":"10.1074\/jbc.274.24.17209","article-title":"ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases","volume":"274","author":"Olayioye","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0580","doi-asserted-by":"crossref","first-page":"18067","DOI":"10.1073\/pnas.1111966108","article-title":"Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease","volume":"108","author":"Olsan","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2020.109639_bb0585","doi-asserted-by":"crossref","first-page":"15679","DOI":"10.1074\/jbc.M114.607929","article-title":"Exploitation of the polymeric immunoglobulin receptor for antibody targeting to renal cyst lumens in polycystic kidney disease","volume":"290","author":"Olsan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109639_bb0590","doi-asserted-by":"crossref","first-page":"F86","DOI":"10.1152\/ajprenal.00346.2017","article-title":"Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease","volume":"315","author":"Olsan","year":"2018","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0595","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ki.2015.207","article-title":"A polycystin-centric view of cyst formation and disease: the polycystins revisited","volume":"88","author":"Ong","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0600","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.1995.62","article-title":"Epidermal growth factor receptor expression is abnormal in murine polycystic kidney","volume":"47","author":"Orellana","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0605","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0610","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","article-title":"The JAK-STAT pathway: impact on human disease and therapeutic intervention","volume":"66","author":"O\u2019Shea","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0615","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease","volume":"44","author":"O\u2019Sullivan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0620","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0625","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/acs.biochem.8b01205","article-title":"The polycystin complex reveals its complexity","volume":"57","author":"Padovano","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2020.109639_bb0630","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-2600(18)30184-X","article-title":"Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials","volume":"6","author":"Panettieri","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0635","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ki.2010.154","article-title":"A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy","volume":"78","author":"Pang","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0640","doi-asserted-by":"crossref","first-page":"580","DOI":"10.15252\/embj.201592383","article-title":"Cytokine-induced megakaryocytic differentiation is regulated by genome-wide loss of a uSTAT transcriptional program","volume":"35","author":"Park","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2020.109639_bb0645","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","article-title":"IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation","volume":"173","author":"Park","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-41106-3","article-title":"Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis","volume":"9","author":"Patera","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cellsig.2020.109639_bb0655","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1242\/dmm.024745","article-title":"Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease","volume":"9","author":"Peda","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.cellsig.2020.109639_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001297","article-title":"STAT2 mediates innate immunity to dengue virus in the absence of STAT1 via the type I interferon receptor","volume":"7","author":"Perry","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cellsig.2020.109639_bb0665","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1093\/nar\/gkv188","article-title":"Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function","volume":"43","author":"Pinz","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0670","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.fct.2017.06.043","article-title":"Stevia and stevioside protect against cisplatin nephrotoxicity through inhibition of ERK1\/2, STAT3, and NF-\u03baB activation","volume":"107","author":"Poto\u010dnjak","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0675","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature15248","article-title":"Erosion of the chronic myeloid leukaemia stem cell pool by PPAR\u03b3 agonists","volume":"525","author":"Prost","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2020.109639_bb0680","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.1073\/pnas.252484899","article-title":"Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations","volume":"99","author":"Qian","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cellsig.2020.109639_bb0685","doi-asserted-by":"crossref","first-page":"F1695","DOI":"10.1152\/ajprenal.00246.2018","article-title":"Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease","volume":"315","author":"Raman","year":"2018","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0690","doi-asserted-by":"crossref","first-page":"F349","DOI":"10.1152\/ajprenal.00478.2014","article-title":"Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2","volume":"308","author":"Ravichandran","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0695","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1242\/jcs.00963","article-title":"The JAK\/STAT signaling pathway","volume":"117","author":"Rawlings","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2020.109639_bb0700","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109639_bb0705","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbi.2017.12.030","article-title":"Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats","volume":"281","author":"Said","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cellsig.2020.109639_bb0710","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1096\/fj.15-279299","article-title":"Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model","volume":"30","author":"Saigusa","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.cellsig.2020.109639_bb0715","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ki.2008.18","article-title":"Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injury","volume":"73","author":"Sandovici","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0720","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00431-019-03384-x","article-title":"Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial","volume":"178","author":"Schaefer","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cellsig.2020.109639_bb0725","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/cea.12220","article-title":"The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge","volume":"44","author":"Scheerens","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cellsig.2020.109639_bb0730","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0735","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cellsig.2020.109639_bb0740","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000286559","article-title":"Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy","volume":"31","author":"Shi","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0745","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/380630a0","article-title":"Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene","volume":"380","author":"Shimoda","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2020.109639_bb0750","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.cr.7310027","article-title":"Regulation of cytokine signaling pathways by PIAS proteins","volume":"16","author":"Shuai","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0755","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","article-title":"Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis","volume":"23","author":"Silva","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109639_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.01.017","article-title":"Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: a randomized, placebo-controlled phase II trial (TREBLE)","volume":"78","author":"Simpson","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0765","series-title":"Kidney Development and Disease","first-page":"323","article-title":"Inflammation and fibrosis in polycystic kidney disease","author":"Song","year":"2017"},{"key":"10.1016\/j.cellsig.2020.109639_bb0770","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00277-019-03708-9","article-title":"Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis","volume":"98","author":"Strati","year":"2019","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0775","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1242\/jcs.045021","article-title":"Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells","volume":"122","author":"Streets","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2020.109639_bb0780","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00441-006-0226-0","article-title":"Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD)","volume":"326","author":"Sweeney","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb0785","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1523-1755.2003.00232.x","article-title":"Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability","volume":"64","author":"Sweeney","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0790","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src Inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0795","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5527\/wjn.v6.i4.188","article-title":"Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease","volume":"6","author":"Sweeney","year":"2017","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0800","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.2012.446","article-title":"Macrophages promote polycystic kidney disease progression","volume":"83","author":"Swenson-Fields","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0805","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1093\/hmg\/ddr338","article-title":"Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways","volume":"20","author":"Takakura","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellsig.2020.109639_bb0810","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/380627a0","article-title":"Essential role of Stat6 in IL-4 signalling","volume":"380","author":"Takeda","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cellsig.2020.109639_bb0815","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1073\/pnas.94.8.3801","article-title":"Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality","volume":"94","author":"Takeda","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0820","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1074-7613(00)80005-9","article-title":"Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils","volume":"10","author":"Takeda","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.cellsig.2020.109639_bb0825","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1073\/pnas.1103816108","article-title":"Polycystin-1 regulates STAT activity by a dual mechanism","volume":"108","author":"Talbot","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0830","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2013091026","article-title":"The cleaved cytoplasmic tail of polycystin-1 regulates src-dependent STAT3 activation","volume":"25","author":"Talbot","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0835","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.kint.2018.05.022","article-title":"JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis","volume":"94","author":"Tao","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0840","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1056\/NEJMoa1608345","article-title":"Baricitinib versus placebo or adalimumab in rheumatoid arthritis","volume":"376","author":"Taylor","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0845","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4065\/mcp.2011.0518","article-title":"Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis","volume":"86","author":"Tefferi","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellsig.2020.109639_bb0850","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1681\/ASN.2016111232","article-title":"Bosutinib versus placebo for autosomal dominant polycystic kidney disease","volume":"28","author":"Tesar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0855","doi-asserted-by":"crossref","first-page":"F511","DOI":"10.1152\/ajprenal.00038.2010","article-title":"Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease","volume":"300","author":"Togawa","year":"2010","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0860","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41581-018-0108-1","article-title":"Progress in the understanding of polycystic kidney disease","volume":"15","author":"Torres","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0865","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"130","author":"Torres","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109639_bb0870","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","article-title":"The HALT polycystic kidney disease trials \u2013 analysis of baseline parameters","volume":"81","author":"Torres","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0875","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0880","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1056\/NEJMoa1402686","article-title":"Angiotensin blockade in late autosomal dominant polycystic kidney disease","volume":"371","author":"Torres","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0885","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0890","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1073\/pnas.94.14.7239","article-title":"Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression","volume":"94","author":"Udy","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109639_bb0895","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev-immunol-032712-095906","article-title":"Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease","volume":"31","author":"Van Dyken","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0900","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2011.12.026","article-title":"SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation","volume":"45","author":"Van Nguyen","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cellsig.2020.109639_bb0905","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb0910","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798615","article-title":"Cilia-localized LKB 1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney","volume":"37","author":"Viau","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2020.109639_bb0915","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/MCB.16.4.1759","article-title":"Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins","volume":"16","author":"Vignais","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0920","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08384","article-title":"Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions","volume":"5","author":"Villarino","year":"2016","journal-title":"ELife"},{"key":"10.1016\/j.cellsig.2020.109639_bb0925","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak\u2013STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0930","doi-asserted-by":"crossref","unstructured":"Wallace, D.P. (2019). Periostin in the kidney. In Periostin, A. Kudo, ed. (Singapore: Springer Singapore), pp. 99\u2013112.","DOI":"10.1007\/978-981-13-6657-4_11"},{"key":"10.1016\/j.cellsig.2020.109639_bb0935","doi-asserted-by":"crossref","first-page":"F1463","DOI":"10.1152\/ajprenal.90266.2008","article-title":"Periostin induces proliferation of human autosomal dominant polycystic kidney cells through \u03b1 V -integrin receptor","volume":"295","author":"Wallace","year":"2008","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0940","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2013.488","article-title":"Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease","volume":"85","author":"Wallace","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb0945","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.cellsig.2010.06.012","article-title":"STAT1 activation regulates proliferation and differentiation of renal progenitors","volume":"22","author":"Wang","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2020.109639_bb0950","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1159\/000112557","article-title":"STAT3 inhibits apoptosis of human renal tubular epithelial cells induced by ATP depletion\/recovery","volume":"108","author":"Wang","year":"2008","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0955","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.2337\/diabetes.51.12.3505","article-title":"Inhibition of the Jak\/STAT signaling pathway prevents the high glucose-induced increase in tgf-beta and fibronectin synthesis in mesangial cells","volume":"51","author":"Wang","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cellsig.2020.109639_bb0960","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jneuroim.2008.11.003","article-title":"A tale of two STAT6 knock out mice in the induction of experimental autoimmune encephalomyelitis","volume":"206","author":"Wang","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0965","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/sj.onc.1203548","article-title":"Activation of Stat3 preassembled with platelet-derived growth factor \u03b2 receptors requires Src kinase activity","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109639_bb0970","doi-asserted-by":"crossref","first-page":"F159","DOI":"10.1152\/ajprenal.00518.2018","article-title":"Periostin and polycystic kidney disease: more pieces in the puzzle","volume":"316","author":"Watanabe","year":"2019","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb0975","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2018080846","article-title":"Are cyst-associated macrophages in polycystic kidney disease the equivalent to TAMs in carncer?","volume":"29","author":"Weimbs","year":"2018","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb0980","doi-asserted-by":"crossref","first-page":"i27","DOI":"10.1093\/ckj\/sfy089","article-title":"Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease","volume":"11","author":"Weimbs","year":"2018","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cellsig.2020.109639_bb0985","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/ndt\/gfu003","article-title":"Impaired renal growth hormone JAK\/STAT5 signaling in chronic kidney disease","volume":"29","author":"Wiezel","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cellsig.2020.109639_bb0990","first-page":"1311","article-title":"The PKD1 gene product, \u201cpolycystin-1,\u201d is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia","volume":"79","author":"Wilson","year":"1999","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cellsig.2020.109639_bb0995","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41375-017-0005-9","article-title":"Pharmacologic inhibition of STAT5 in acute myeloid leukemia","volume":"32","author":"Wingelhofer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.cellsig.2020.109639_bb1000","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2017.23","article-title":"The emerging safety profile of JAK inhibitors in rheumatic disease","volume":"13","author":"Winthrop","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1005","article-title":"Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases","volume":"11","author":"Winyard","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2018.05.029","article-title":"Treatment of atopic dermatitis with tralokinumab, an anti\u2013IL-13 mAb","volume":"143","author":"Wollenberg","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012305","article-title":"Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca2+ entry through interactions with STIM1","volume":"5","author":"Woodward","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cellsig.2020.109639_bb1020","doi-asserted-by":"crossref","first-page":"F1284","DOI":"10.1152\/ajprenal.00428.2015","article-title":"The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1","volume":"310","author":"Wu","year":"2016","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1025","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1038\/sj.onc.1203485","article-title":"The biology of Stat4 and Stat6","volume":"19","author":"Wurster","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109639_bb1030","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the TH1\/TH2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/labinvest.2009.11","article-title":"Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells","volume":"89","author":"Xiong","year":"2009","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cellsig.2020.109639_bb1040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2013060611","article-title":"IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium","volume":"25","author":"Xu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1045","first-page":"1","article-title":"Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction","author":"Xu","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1050","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1681\/ASN.2014070717","article-title":"JAK3\/STAT6 stimulates bone marrow-derived fibroblast activation in renal fibrosis","volume":"26","author":"Yan","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/cr.2008.41","article-title":"Roles of unphosphorylated STATs in signaling","volume":"18","author":"Yang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.cellsig.2020.109639_bb1060","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1681\/ASN.2013030217","article-title":"Adiponectin promotes monocyte-to-fibroblast transition in renal fibrosis","volume":"24","author":"Yang","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1065","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1681\/ASN.2018010074","article-title":"Interactions between macrophages and cyst-lining epithelial cells promote kidney cyst growth in Pkd1 -deficient mice","volume":"29","author":"Yang","year":"2018","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb1070","doi-asserted-by":"crossref","first-page":"F677","DOI":"10.1152\/ajprenal.00119.2017","article-title":"The regulatory 1\u03b1 subunit of protein kinase A modulates renal cystogenesis","volume":"313","author":"Ye","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1075","doi-asserted-by":"crossref","first-page":"F319","DOI":"10.1152\/ajprenal.00432.2002","article-title":"Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia-reperfusion injury","volume":"285","author":"Yokota","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1085","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2020.109639_bb1090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bcp.2014.01.038","article-title":"Steviol retards renal cyst growth through reduction of CFTR expression and inhibition of epithelial cell proliferation in a mouse model of polycystic kidney disease","volume":"88","author":"Yuajit","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1095","first-page":"225","article-title":"STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy","volume":"15","author":"Yukawa","year":"2005","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb1100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10753-017-0659-5","article-title":"A novel role of a chemotherapeutic agent in a rat model of endotoxemia: modulation of the STAT-3 signaling pathway","volume":"41","author":"Zaki","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.cellsig.2020.109639_bb1105","first-page":"25","article-title":"Renoprotective effect of erythropoietin via modulation of the STAT6\/MAPK\/NF-\u03baB pathway in ischemia\/reperfusion injury after renal transplantation","volume":"41","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb1110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.kint.2016.08.020","article-title":"IL-4\/IL-13\u2013mediated polarization of renal macrophages\/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury","volume":"91","author":"Zhang","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109639_bb1115","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.481","article-title":"STAT1\u03b2 enhances STAT1 function by protecting STAT1\u03b1 from degradation in esophageal squamous cell carcinoma","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2020.109639_bb1120","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1073\/pnas.0501063102","article-title":"Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation\u2013inactivation cycle","volume":"102","author":"Zhong","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.cellsig.2020.109639_bb1125","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1681\/ASN.2012080849","article-title":"miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1","volume":"24","author":"Zhou","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb1130","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.cellsig.2013.05.007","article-title":"Regulation of STAT Signaling by Acetylation","volume":"25","author":"Zhuang","year":"2013","journal-title":"Cell. Signal."},{"key":"10.1016\/j.cellsig.2020.109639_bb1135","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1681\/ASN.2018080810","article-title":"Tissue-resident macrophages promote renal cystic disease","volume":"30","author":"Zimmerman","year":"2019","journal-title":"JASN"},{"key":"10.1016\/j.cellsig.2020.109639_bb1140","article-title":"Interferon regulatory factor 5 in resident macrophage promotes polycystic kidney disease","volume":"360","author":"Zimmerman","year":"2020","journal-title":"Kidney"},{"key":"10.1016\/j.cellsig.2020.109639_bb3000","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2147\/DDDT.S81390","article-title":"Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Design, Develop. Ther."},{"key":"10.1016\/j.cellsig.2020.109639_bb3005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/aps.2014.42","article-title":"Inhibition of STAT3 acetylation is associated with angiotesin renal fibrosis in the obstructed kidney.","volume":"35","author":"Ni","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cellsig.2020.109639_bb3010","doi-asserted-by":"crossref","first-page":"F303","DOI":"10.1152\/ajprenal.00102.2014","article-title":"Class I HDAC activity is required for renal protection and regeneration after acute kidney injury.","volume":"307","author":"Tang","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molonc.2012.02.002","article-title":"Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling.","volume":"6","author":"Nam","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cbic.200700701","article-title":"Discovery of chromone-based inhibitors of the transcription factor STAT5.","volume":"9","author":"M\u00fcller","year":"2008","journal-title":"Chembiochem\u202f: A Eur. J. Chem. Biol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3025","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.2215\/CJN.03960318","article-title":"Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease","volume":"13","author":"Chebib","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3030","first-page":"1022","article-title":"Elevated interleukin-13 in patients with active lupus nephritis.","volume":"114","author":"Chen","year":"2001","journal-title":"Chinese Medical Journal"},{"key":"10.1016\/j.cellsig.2020.109639_bb3035","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/joim.12214","article-title":"Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease","volume":"276","author":"Su","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cellsig.2020.109639_bb3040","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2011050442","article-title":"Kidney Injury Accelerates Cystogenesis via Pathways Modulated by Heme Oxygenase and Complement","volume":"23","author":"Zhou","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3045","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2019090959","article-title":"Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease","volume":"31","author":"Viau","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109639_bb3050","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1093\/ndt\/gfn288","article-title":"Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR.","volume":"23","author":"Arbeiter","year":"2008","journal-title":"Nephrol. Dialysis Transplant."},{"key":"10.1016\/j.cellsig.2020.109639_bb3055","doi-asserted-by":"crossref","first-page":"G155","DOI":"10.1152\/ajpgi.00311.2015","article-title":"JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines.","volume":"310","author":"Danese","year":"2015","journal-title":"J. Physiol. Gastroint. Liver Physiol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820301169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820301169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:00:46Z","timestamp":1760266846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820301169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":238,"alternative-id":["S0898656820301169"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109639","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STAT signaling in polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109639"}}